Special Symposium
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Chairs
  • Robert L. Coleman (The Woodlands, TX, United States of America)
  • Susana Banerjee (London, United Kingdom)
Special Symposium

Why are we having this Symposium? Recent regulatory actions by FDA/EMEA regarding late-stage approval for PARPi in recurrent ovarian cancer

Speakers
  • Robert L. Coleman (The Woodlands, TX, United States of America)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium

Is there clinical evidence to support the link between PARPi use and a negative impact on OS?

Speakers
  • Jonathan A. Ledermann (London, London, United Kingdom)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium

Is there a biological rationale to support decremental impact on overall survival?

Speakers
  • Antonio Jose Gonzalez Martin (Madrid, Spain)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium

What is the impact of overall survival results of PARP inhibitor trials?

Speakers
  • Susana Banerjee (London, United Kingdom)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium

Q&A

Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
20 Minutes